News & Events

We are pleased to share the next step of Mar Medica’s evolution and how this change will benefit you and are delighted to announce that as of January 2nd, 2024, Mar Medica will formally be known as Duomed Southeast Europe.

Duomed is appointing Reinier van der List as Executive Chairman of the Board, Frederic Hoffmann as Chief Executive Officer, effective November 1st 2023.

We are pleased to announce that we have joined the United Nations Global Compact initiative — a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.

December 2, 2022 – Duomed Group is pleased to announce the acquisition of Mar Medica Ltd., based in Belgrade (Serbia).